Speaker(s): 

Miranda Woosman, PharmD, PGY1 Pharmacy Resident, Geisinger - has nothing to disclose.

Moderator(s):

Christopher DeFrancesco PharmD, Acute Care Clinical Pharmacist, Geisinger -  has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Recognize the clinical signs, symptoms, and laboratory findings of drug-induced SIADH.

2. Identify common drugs associated with SIADH and their mechanisms of action.

3. Implement appropriate management strategies for patients with drug-induced SIADH.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None